BG61101B1 - Антиалергичен състав с очно и назално приложение - Google Patents

Антиалергичен състав с очно и назално приложение Download PDF

Info

Publication number
BG61101B1
BG61101B1 BG98327A BG9832793A BG61101B1 BG 61101 B1 BG61101 B1 BG 61101B1 BG 98327 A BG98327 A BG 98327A BG 9832793 A BG9832793 A BG 9832793A BG 61101 B1 BG61101 B1 BG 61101B1
Authority
BG
Bulgaria
Prior art keywords
solution
cyclodextrin
cetirizine
composition
allergic
Prior art date
Application number
BG98327A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98327A (bg
Inventor
Yoshifumi Ikejiri
Takahiro Ogawa
Fuminori Tokumochi
Shogo Sameshima
Motoko Kimura
Original Assignee
Senju Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co.,Ltd. filed Critical Senju Pharmaceutical Co.,Ltd.
Publication of BG98327A publication Critical patent/BG98327A/bg
Publication of BG61101B1 publication Critical patent/BG61101B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG98327A 1992-12-25 1993-12-23 Антиалергичен състав с очно и назално приложение BG61101B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34603192 1992-12-25

Publications (2)

Publication Number Publication Date
BG98327A BG98327A (bg) 1994-08-30
BG61101B1 true BG61101B1 (bg) 1996-11-29

Family

ID=18380671

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98327A BG61101B1 (bg) 1992-12-25 1993-12-23 Антиалергичен състав с очно и назално приложение

Country Status (23)

Country Link
US (1) US5419898A (ru)
EP (1) EP0605203B1 (ru)
JP (1) JP3683595B2 (ru)
KR (1) KR100276743B1 (ru)
CN (1) CN1050514C (ru)
AT (1) ATE164068T1 (ru)
AU (1) AU666413B2 (ru)
BG (1) BG61101B1 (ru)
CA (1) CA2112014C (ru)
CZ (1) CZ283029B6 (ru)
DE (1) DE69317537T2 (ru)
DK (1) DK0605203T3 (ru)
ES (1) ES2115733T3 (ru)
FI (1) FI111805B (ru)
HU (2) HU218672B (ru)
LT (1) LT3344B (ru)
LV (1) LV10688B (ru)
NO (2) NO934630D0 (ru)
NZ (1) NZ250519A (ru)
PL (1) PL173347B1 (ru)
RU (1) RU2130774C1 (ru)
SK (1) SK279503B6 (ru)
TW (1) TW401300B (ru)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
AU714913B2 (en) * 1996-09-27 2000-01-13 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same
BE1011251A3 (fr) * 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
EP0919550A1 (en) * 1997-11-26 1999-06-02 Ucb, S.A. Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
WO2000012137A1 (en) 1998-09-02 2000-03-09 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
JP2001125052A (ja) * 1999-10-25 2001-05-11 Lion Corp コンタクトレンズ装着液
US6258814B1 (en) * 2000-10-13 2001-07-10 Schering Corporation Method of using cetirizine and pharmaceutical compositions containing the same for inducing sleep
EP1467715B1 (en) * 2002-01-15 2010-11-03 Ucb Farchim S.A. Formulations for oral administration of active compounds
JP4543274B2 (ja) * 2002-10-01 2010-09-15 大正製薬株式会社 点鼻剤組成物
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20050255154A1 (en) * 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
JP2006008568A (ja) * 2004-06-24 2006-01-12 Cyclochem:Kk ＩｇＥ抗体抑制剤および食品
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
US20080075784A1 (en) * 2004-07-22 2008-03-27 Pfizer Inc. Taste Making Formulation Comprising The Drug In A Dissolution-Retarded Form And/Or Cyclodextrin In A Dissolution-Enhanced Form
ES2393768T3 (es) 2005-05-26 2012-12-27 Neuron Systems, Inc Derivado de quinolina para el tratamiento de enfermedades retinianas
JPWO2006137433A1 (ja) * 2005-06-21 2009-01-22 わかもと製薬株式会社 レボカバスチンを可溶化させた水性薬剤
EP3449928A1 (en) * 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
AU2007225798B2 (en) * 2006-03-13 2012-09-06 R-Tech Ueno, Ltd. Aqueous composition
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
CN101284026B (zh) * 2007-04-12 2010-11-10 鲁南制药集团股份有限公司 一种用于治疗皮肤过敏性疾病的药物组合物
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
PT2408453T (pt) * 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
KR20120059545A (ko) * 2009-08-12 2012-06-08 루난 베터 파마슈티칼 씨오., 엘티디 세티리진염산염 약용액
EP2496593B1 (en) 2009-11-06 2015-08-12 Yale University Amphiphilic compositions and methods for preparing and using same
CA2852716C (en) 2011-11-29 2015-11-17 Jurox Pty Ltd Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
KR102435676B1 (ko) 2013-01-23 2022-08-24 알데이라 테라퓨틱스, 아이엔씨. 독성 알데히드 관련된 질병 및 치료
AU2016311158A1 (en) 2015-08-21 2018-04-05 Aldeyra Therapeutics, Inc. Deuterated compounds and uses thereof
EP3419633A4 (en) * 2016-02-28 2019-10-30 Aldeyra Therapeutics, Inc. TREATMENT OF ALLERGIC EYE DISEASES WITH CYCLODEXTRINS
EP3454858A4 (en) 2016-05-09 2020-01-15 Aldeyra Therapeutics, Inc. POLYTHERAPY OF DISORDERS AND INFLAMMATORY EYE DISEASES
JP6843896B2 (ja) * 2017-02-13 2021-03-17 日東メディック株式会社 水性点眼点鼻用組成物
JP2020511461A (ja) 2017-03-16 2020-04-16 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
AU2018348174A1 (en) 2017-10-10 2020-04-23 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
ES2878107T3 (es) * 2018-01-18 2021-11-18 Faes Farma Sa Composiciones oftálmicas que comprenden bilastina, una beta-ciclodextrina y al menos un agente de gelificación
JP2021533154A (ja) 2018-08-06 2021-12-02 アルデイラ セラピューティクス， インコーポレイテッド 多形化合物およびその使用
CN113056353B (zh) 2018-09-25 2022-11-01 奥尔德拉医疗公司 用于治疗干眼病的调配物
WO2020198064A1 (en) 2019-03-26 2020-10-01 Aldeyra Therapeutics, Inc. Ophthalmic formulations and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
NZ224497A (en) * 1987-05-18 1990-04-26 Janssen Pharmaceutica Nv Pharmaceutical composition comprising flunarizine
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) * 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
JPH06311353A (ja) 1993-04-19 1994-11-04 Brother Ind Ltd カラー画像形成装置
JP2619828B2 (ja) 1996-06-17 1997-06-11 九州日立マクセル株式会社 電動式爪みがき機

Also Published As

Publication number Publication date
HU218672B (hu) 2000-10-28
FI935851A (fi) 1994-06-26
JPH06239748A (ja) 1994-08-30
FI111805B (fi) 2003-09-30
KR100276743B1 (ko) 2001-01-15
RU2130774C1 (ru) 1999-05-27
NO934630D0 (no) 1993-12-15
CA2112014C (en) 2004-11-02
EP0605203A2 (en) 1994-07-06
KR940013511A (ko) 1994-07-15
FI935851A0 (fi) 1993-12-23
LT3344B (en) 1995-07-25
PL301588A1 (en) 1994-06-27
NZ250519A (en) 1995-03-28
LTIP1669A (en) 1994-10-25
TW401300B (en) 2000-08-11
NO934630L (no) 1994-06-27
HU211972A9 (en) 1996-01-29
DE69317537D1 (de) 1998-04-23
JP3683595B2 (ja) 2005-08-17
HU9303746D0 (en) 1994-04-28
HUT69385A (en) 1995-09-28
DK0605203T3 (da) 1998-12-07
BG98327A (bg) 1994-08-30
CZ283029B6 (cs) 1997-12-17
AU666413B2 (en) 1996-02-08
PL173347B1 (pl) 1998-02-27
SK147493A3 (en) 1994-07-06
ATE164068T1 (de) 1998-04-15
SK279503B6 (sk) 1998-12-02
LV10688B (en) 1995-10-20
CA2112014A1 (en) 1994-06-26
EP0605203B1 (en) 1998-03-18
DE69317537T2 (de) 1998-07-09
LV10688A (lv) 1995-06-20
US5419898A (en) 1995-05-30
ES2115733T3 (es) 1998-07-01
AU5259793A (en) 1994-07-07
CN1094614A (zh) 1994-11-09
NO304176B1 (no) 1998-11-09
CZ283693A3 (en) 1994-07-13
EP0605203A3 (en) 1994-11-02
CN1050514C (zh) 2000-03-22

Similar Documents

Publication Publication Date Title
BG61101B1 (bg) Антиалергичен състав с очно и назално приложение
KR100889170B1 (ko) 안구 건조의 치료에 있어서 리멕솔론의 용도
EP0306984B1 (en) Preservative system for ophtalmic formulations
ES2399045T3 (es) Combinación de brimonidina y timolol para uso oftálmico tópico
JP2769253B2 (ja) 水性液剤
US6476039B1 (en) Ophthalmic composition
JPH05201854A (ja) 長期放出性眼用製剤
CN103976943B (zh) 用于治疗或预防眼部疼痛的酮咯酸氨丁三醇组合物
JP2787131B2 (ja) 水性懸濁液剤
JPH085779B2 (ja) フレロキサシン点眼液
KR102266014B1 (ko) 안질환 예방 또는 치료용 점안 조성물
TW202114697A (zh) 用於穩定包括藥物的水性組成物之pH值的方法
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
NZ264616A (en) Compositions for treating myopia containing a 7-alkyl-5-oxo-benzopyrano[2,3-b]pyridine derivative
JPH10500130A (ja) テラゾシンを含有する緑内障治療用医薬組成物
JP2004168709A (ja) 抗アレルギー点眼点鼻用組成物
MX2011005586A (es) Composiciones de soluciones oculares topicas para suministrar concentraciones efectivas de agente activo al segmento posterior del ojo.
JPH02262518A (ja) 眼圧調整剤
JPH10203979A (ja) チアプロフェン酸を含有する抗眼炎症剤
CN113710227A (zh) 减少组合在一起用于眼科用途的抗生素-抗炎药组合物中的抗生素剂量
WO1998057646A1 (fr) Preparations medicinales aqueuses a base de difluprednate solubilise destinees a un usage externe
JPH09295935A (ja) 抗眼炎症剤